Resources
Filter by Topic
- Publication
Podium and posters at ICPE All Access Virtual Meeting, September 16-17, 2020.
- Press Releases
Panalgo’s new Data Science module seamlessly integrates machine-learning techniques to identify new insights for patient care
- News & Events
ICPE All Access: 35 Years of Real-World Science September 16-17, 2020
- Articles
Life Science Leader article from VP of Modeling & Evidence, Matt Sussman.
- Publication
Authors: Matthew Sussman, Jeffrey C Yu, Joseph Menzin Published: Applied Health Economics Health Policy Click here to view the article.
- Press Releases
Panalgo, which conveys “an algorithm for everything,” aligns with company vision of streamlining analytics, enabling pharma, payers, and providers to make more impactful decisions
Pregnancy rates and outcomes in women with and without MS in the United States
Authors: MK Houtchens, NC Edwards, G Schneider, K Stern, AL Phillips Published: Neurology, 2018. Click here for the article.
Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives
Authors: Matthew Sussman, Jennifer Benner, Peter Neumann, Joseph Menzin Published: Cephalalgia, 2018. Click here for the full article.
Predictors of All-Cause Healthcare Payments Among Patients with Treatment-Resistant Major Depressive Disorder
Authors: M Sussman, A O’Sullivan, A Shah, J Menzin, M Olfson Published: Value in Health, ISPOR 2018 Click here for the article.
Real-World Bleeding Risks in Non-Valvular Atrial Fibrillation Patients with Heart Failure: Contemporary HER Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban, and Warfarin.
Authors: Iris Lin, Ruslan Horblyuk, Jack Mardekian, Sang Hee Park, Shital Kamble, Melissa Hamilton, Younos Abdulsattar, William Petkun, Joseph Menzin, and Gregory Y Lip Published: Circulation,
Comorbidity in US patients with multiple sclerosis
Authors: N Edwards, M Munsell, J Menzin, A Phillips Published: Patient Related Outcome Measures, 2018 Click here to view.
Development and validation of a claims-based measure as an indicator for disease severity in patients with multiple sclerosis treated with disease-modifying drugs
Authors: Michael Munsell, Molly Frean, Joseph Menzin, and Amy L. Phillips Published: BMC Neurology Click here for the article.
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization